Pandemic rattles already vulnerable antibiotics market

  04 April 2020

A report from the biopharmaceutical industry published earlier this year found that 47% of the 65 responding companies experienced product supply chain disruptions of antibiotics.

With more countries shutting borders, trade restrictions in India and manufacturing disruptions in China, there are growing concerns that meeting rising demand could prove even more difficult.

Enea Martinelli, head pharmacist at the FMI hospital in Interlaken told swissinfo.ch that hospitals in Switzerland are getting organised and that supply isn’t a problem now. But he worries about what’s ahead in a few months’ time.

Further reading: SwissInfo.CH
Author(s): Jessica Davis Plüss
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!